AI-assisted, human-published
08/06/2025 /Funding Events
Retension Pharmaceuticals Secures $15M Series B Financing for Hypertension Treatment
Retension Pharmaceuticals announces successful closing of $15M Series B financing to advance RTN-001 for patients with uncontrolled and resistant hypertension.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com